Neutralization of TNF-α using a TNF-α inhibitor, such as etanercept, is of increased interest as it leads to disruption of granuloma integrity, which in turn augments anti-TB drug response and reduces lung pathology [116,117,118]. The gene discussed is TNF; the disease is tuberculosis.